Interleukin-2 Receptor Antagonists in Liver Transplantation: A Meta-analysis of Randomized TrialsWANG, X. F; LI, J. D; PENG, Y et al.Transplantation proceedings. 2010, Vol 42, Num 10, pp 4567-4572, issn 0041-1345, 6 p.Article

Interleukin-2 Receptor Antibody Reduces Rejection Rates and Graft Loss in Live-Donor Kidney Transplant RecipientsLIM, Wai H; CHANG, Sean H; CHADBAN, Steve J et al.Transplantation. 2009, Vol 88, Num 10, pp 1208-1213, issn 0041-1337, 6 p.Article

Stem Cell Factor, Interleukin-16, and Interleukin-2 Receptor Alpha are Predictive Biomarkers for Delayed and Slow Graft FunctionALACHKAR, N; UGARTE, R; HUANG, E et al.Transplantation proceedings. 2010, Vol 42, Num 9, pp 3399-3405, issn 0041-1345, 7 p.Article

The Interleukin-2 Receptor α Chain (CD25) Plays an Important Role in Regulating Monocyte-Derived CD40 Expression During Anti-Porcine Cellular ResponsesSUN, Z.-G; WANG, Z; ZHU, L.-M et al.Transplantation proceedings. 2012, Vol 44, Num 4, pp 1139-1142, issn 0041-1345, 4 p.Conference Paper

Alemtuzumab Versus Interleukin-2 Receptor Antibodies Induction in Living Donor Kidney TransplantationSAMPAIO, Marcelo S; KADIYALA, Aditya; GILL, Jagbir et al.Transplantation. 2009, Vol 88, Num 7, pp 904-910, issn 0041-1337, 7 p.Article

HLA Mismatches Remain Risk Factors for Acute Kidney Allograft Rejection in Patients Receiving Quadruple Immunosuppression With Anti-Interleukin-2 Receptor Antibodies. CommentaryMARSH, James E; ANDREWS, Peter A; ABRAMOWICZ, Daniel et al.Transplantation. 2008, Vol 85, Num 3, issn 0041-1337, 312-313, 411-416 [8 p.]Article

Late Acute Humoral Rejection in Low-Risk Renal Transplant Recipients Induced With an Interleukin-2 Receptor Antagonist and Maintained With Standard Therapy: Preliminary CommunicationMORALES, J; CONTRERAS, L; BUCKEL, E et al.Transplantation proceedings. 2011, Vol 43, Num 6, pp 2295-2299, issn 0041-1345, 5 p.Conference Paper

Serum soluble interleukin-2 receptor level and immunophenotype are prognostic factors for patients with diffuse large B-cell lymphomaMORITO, Toshiaki; FUJIHARA, Megumu; ASAOKU, Hideki et al.Cancer science. 2009, Vol 100, Num 7, pp 1255-1260, issn 1347-9032, 6 p.Article

The relationship between thyroid function, serum monokine induced by interferon gamma and soluble interleukin-2 receptor in thyroid autoimmune diseasesJISKRA, J; ANTOSOVA, M; LIMANOVA, Z et al.Clinical and experimental immunology (Print). 2009, Vol 156, Num 2, pp 211-216, issn 0009-9104, 6 p.Article

Organophosphorous pesticide metabolite (DEDTP) induces changes in the activation status of human lymphocytes by modulating the interleukin 2 receptor signal transduction pathwayESQUIVEL-SENTIES, M. S; BARRERA, I; ORTEGA, A et al.Toxicology and applied pharmacology. 2010, Vol 248, Num 2, pp 122-133, issn 0041-008X, 12 p.Article

Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumabSLOAND, Elaine M; OLNES, Matthew J; WEINSTEIN, Barbara et al.Haematologica (Roma). 2010, Vol 95, Num 3, pp 382-387, issn 0390-6078, 6 p.Article

Serum soluble interleukin 2 receptor (sIL-2R) as a marker of acute rejection in renal transplant childrenGARCIA-ROCA, P; VARGAS, Y. A; FUENTES, Y et al.Pediatric transplantation. 2012, Vol 16, Num 3, pp 274-279, issn 1397-3142, 6 p.Article

Safety and pharmacokinetics of daclizumab in pediatric renal transplant recipientsPESCOVITZ, Mark D; KNECHTLE, Stuart; ALEXANDER, Steven R et al.Pediatric transplantation. 2008, Vol 12, Num 4, pp 447-455, issn 1397-3142, 9 p.Article

Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapyENNISHI, D; YOKOYAMA, M; TANIMOTO, M et al.Annals of oncology. 2009, Vol 20, Num 3, pp 526-533, issn 0923-7534, 8 p.Article

Cerebriform variant type of T cell prolymphocytic leukemia with complex karyotype including an additional segment at 1p36.1KASAHARA, Senji; TSURUMI, Hisashi; SHIBATA, Yuhei et al.International journal of hematology. 2012, Vol 96, Num 5, pp 674-678, issn 0925-5710, 5 p.Article

Soluble interleukin-2 receptor serum level is a useful marker of hidradenitis suppurativa clinical stagingMATUSIAK, Lukasz; BIENIEK, Andrzej; SZEPIETOWSKI, Jacek C et al.Biomarkers (London. Print). 2009, Vol 14, Num 6, pp 432-437, issn 1354-750X, 6 p.Article

Genetic Association between the Interleukin-2 Receptor-a Gene and Mode of Onset of Type 1 Diabetes in the Japanese PopulationKAWASAKI, Eiji; AWATA, Takuya; TANAKA, Shoichiro et al.The Journal of clinical endocrinology and metabolism. 2009, Vol 94, Num 3, pp 947-952, issn 0021-972X, 6 p.Article

Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AMLTERWIJN, Monique; FELLER, Nicole; VAN RHENEN, Anna et al.European journal of cancer (1990). 2009, Vol 45, Num 9, pp 1692-1699, issn 0959-8049, 8 p.Article

Serum-soluble interleukin-2 receptor (sIL-2R) is an extremely strong prognostic factor for patients with peripheral T-cell lymphoma, unspecified (PTCL-U)KITAGAWA, Jun-Ichi; HARA, Takeshi; SHIMIZU, Masahito et al.Journal of cancer research and clinical oncology. 2009, Vol 135, Num 1, pp 53-59, issn 0171-5216, 7 p.Article

Multivariate analysis of antibody induction therapy and their associated outcomes in live donor kidney transplantation in the recent eraEMAMI, Sina; HUANG, Edmund; KUO, Hung-Tien et al.Clinical transplantation. 2012, Vol 26, Num 2, pp 351-358, issn 0902-0063, 8 p.Article

Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosisBARAK, V; SELMI, C; SCHLESINGER, M et al.Journal of autoimmunity (Print). 2009, Vol 33, Num 3-4, pp 178-182, issn 0896-8411, 5 p.Article

Non-obese diabetic-recombination activating gene-1 (NOD-Rag1^null) interleukin (IL)-2 receptor common gamma chain (IL2rγ^null) null mice : a radioresistant model for human lymphohaematopoietic engraftmentPEARSON, T; SHULTZ, L. D; FOREMAN, O et al.Clinical and experimental immunology (Print). 2008, Vol 154, Num 2, pp 270-284, issn 0009-9104, 15 p.Article

The Effect of Costimulatory and Interleukin 2 Receptor Blockade on Regulatory T Cells in Renal TransplantationBLUESTONE, J. A; LIU, W; YABU, J. M et al.American journal of transplantation (Print). 2008, Vol 8, Num 10, pp 2086-2096, issn 1600-6135, 11 p.Article

Soluble interleukin-2 receptor level on day 7 as a predictor of graft-versus-host disease after HLA-haploidentical stem cell transplantation using reduced-intensity conditioningKAIDA, Katsuji; IKEGAME, Kazuhiro; SOMA, Toshihiro et al.International journal of hematology. 2014, Vol 99, Num 4, pp 463-470, issn 0925-5710, 8 p.Article

Early Relapse Is Associated with High Serum Soluble Interleukin-2 Receptor after the Sixth Cycle of R-CHOP Chemotherapy in Patients with Advanced Diffuse Large B-Cell LymphomaYAMAUCHI, Takahiro; MATSUDA, Yasufumi; YOSHIDA, Akira et al.Anticancer research. 2012, Vol 32, Num 11, pp 5051-5057, issn 0250-7005, 7 p.Article